Variable phenotypes in a family with mitochondrial encephalomyopathy harboring a 3291T > C mutation in mitochondrial DNA by Sunami, Yoko et al.
ORIGINAL ARTICLE
Variable phenotypes in a family with mitochondrial
encephalomyopathy harboring a 3291T > C mutation
in mitochondrial DNA
Yoko Sunami • Keizo Sugaya • Norio Chihara •
Yu-ichi Goto • Shiro Matsubara
Received: 2 June 2010/Accepted: 16 July 2011/Published online: 24 August 2011
 The Author(s) 2011. This article is published with open access at Springerlink.com
Abstract We present a Japanese family suffering from
mitochondrial encephalomyopathy associated with a T-to-
C transition at mitochondrial DNA (mtDNA) nucleotide
position 3291. Clinical manifestations of the patients
include cerebellar ataxia with myopathy, recurrent head-
ache, and myoclonus and epilepsy. The phenotypic vari-
ation among the affected members of a single family and
the mutational analysis showing maternal inheritance in a
heteroplasmic fashion are consistent with well-recognized
phenomena associated with many pathogenic point
mutations of mtDNA tRNA genes. The 3291 mutation is
a rare mtDNA mutation whose clinical presentation had
only been reported in three sporadic cases. This is the
ﬁrst report of a family segregating the 3291 mutation
with multigenerational matrilinear recurrence of mito-
chondrial encephalopathy. Our ﬁndings provide conclu-
sive evidence for the pathogenicity of the 3291T[C
mutation in mtDNA and its characteristic clinical
heterogeneity.
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Introduction
With recent advances in molecular genetic analysis, an
increasing number of different nucleotide substitutions in
mitochondrial DNA (mtDNA) have been identiﬁed in
patients with mitochondrial encephalomyopathy. Point
mutations in mitochondrial tRNA genes, in particular, are
commonly associated with mitochondrial diseases. Cur-
rently, more than 90 different mutations within mito-
chondrial tRNA genes have been characterized as
pathogenic (MITOMAP: A Human Mitochondrial Gen-
ome Database, http://www.mitomap.org). Among the
most prevalent of these point mutations are the 3243 and
3271 mutations, which are closely associated with the
syndrome of mitochondrial myopathy, encephalopathy,
lactic acidosis, and stroke-like episodes (MELAS). The
3291 mutation in mtDNA was ﬁrst identiﬁed in a single
Japanese patient with a typical MELAS phenotype [1].
Like the 3243 and 3271 mutations, the 3291 mutation in
mtDNA is located in the tRNA-Leu(UUR) gene. Thus,
this mutation is also thought to be associated with the
MELAS phenotype. In contrast to the original patient,
the second case associated with the 3291 mutation was
reported in an Italian child affected by an apparently
isolated, mild myopathy [2]. The third case with the
same mutation was an Italian female who suffered
from progressive cognitive and behavioral decline, and
hearing loss [3]. Here we describe a Japanese family
that represents the fourth case—and the ﬁrst familial
case—of mitochondrial encephalomyopathy harboring a
3291T[C mtDNA mutation, and show that the clinical
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Case report
Figure 1a shows the pedigree of our patients. A 70-year-
old woman (II-4) was admitted to our hospital due to a
6-year history of progressive gait disturbance. At the age of
45 years, she developed bilateral hearing deﬁcits, and at
64 years, she underwent surgery to correct cataracts and
glaucoma. Neurological examination of the patient
revealed mild external ophthalmoparesis, nystagmus, sen-
sory neural hearing loss, dysarthria, and severe cerebellar
ataxia. There was mild proximal muscle weakness of the
limbs. Tendon reﬂexes were reduced generally. Electro-
encephalogram (EEG) assessment showed diffuse parox-
ysmal slow activity (3–6 Hz), which was induced by
photo-stimulation. No epileptic discharge was found.
Needle electromyography showed low amplitude and short
motor-unit potential in the proximal extremities. Brain
magnetic resonance imaging (MRI) showed atrophy of
frontal lobe and cerebellar cortex (Fig. 2). There was no
lactate peak on brain magnetic resonance spectroscopy in a
voxel placed over a lateral ventricle. Laboratory test results
revealed normal lactate levels and slightly increased
pyruvic acid levels. Cerebrospinal ﬂuid analysis was nor-
mal. The psychometric test showed impaired intelligence,
memory, and frontal function.
The proband’s mother (I-2) suffered from hearing loss
and glaucoma. Since the age of 80, she had slowly become
progressively bedridden. She died at the age of 84.
The proband’s ﬁrst daughter (III-2) is 41 years old and
has had palindromic rheumatism since the age of 14 years.
She has not experienced convulsion, myoclonic event or
stroke-like episodes, but has had recurrent migraine
attacks. Brain MRI showed multiple, small hyper-intense
areas in subcortical white matter of the cerebrum on a T2-
weighted sequence. Her neurological examination showed
no abnormalities.
The proband’s second daughter (III-3) is 39 years old
and has experienced photo-induced myoclonus since the
age 36 years. At that time, atrophy of the cerebellum was
noted on MRI. At the age of 38 years, she started taking
anticonvulsant medication due to negative myoclonus and
photo-induced myoclonus on EEG examination. Her neu-
rological examination showed an absence of tendon
reﬂexes in all limbs and mild truncal ataxia. Muscle
strength and mental status were normal.
The proband’s ﬁrst granddaughter (IV-1) is 17 years
old. She was delivered with the aid of a vacuum extractor
at 37 gestational weeks. At the age of 15 years, loss of
Fig. 1 a Pedigree of our patients. Proband is indicated by arrow.
Open squares and circles denote healthy relatives; ﬁlled squares and
circles indicate the affected offspring. b PCR–RFLP analysis using a
modiﬁed set of primers that speciﬁcally detects the 3291 mutation.
PCR ampliﬁcation yields a 309-bp product that is cleaved to a 280-bp
product by BamHI digestion in individuals carrying the 3291
mutation, but not in individuals with wild-type mtDNA. PCR
products were separated on 4% agarose gel and visualized by
ethidium bromide staining. DNA was not obtained from the patients
of I-2 and III-2
Fig. 2 The T2 MRI sequences in patient II-4 showed apparent
atrophy of the frontal lobe and cerebellar cortex
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123consciousness lasting a few seconds and myoclonic jerks in
her upper extremities and trunk appeared. Two years later,
she experienced her ﬁrst generalized seizure with an
abnormal EEG record and started taking antiepileptic
drugs. School records indicated below average academic
performance. Her neurological examination showed an
absence of tendon reﬂexes in all four limbs and slight
cognitive decline. Coordination and muscle strength were
normal.
Otherwise, there are no other family members known to
have any endocrine or neurological disease.
Materials and methods
A muscle biopsy was performed in the proband patient
(Fig. 1a II-4) on the left bicep muscle, and serial frozen
sections were stained with hematoxylin and eosin (H&E),
modiﬁed Gomori trichrome and a range of histochemical
stains.
DNA samples were prepared from the muscle biopsy and
heparinized blood specimens from the proband and from
her symptomatic daughters and grandchild. DNA was
extracted from muscle as previously described [1], and from
whole blood using standard procedures. PCR-restriction
fragment length polymorphism (RFLP) was performed as
previously described [1]. Brieﬂy, PCR reactions were per-
formed using a modiﬁed primer containing a G-to-C mis-
match at 3286 and a G-to-A mismatch at 3289 to generate
309-bp products, which were then digested by BamHI. In
the presence of the 3291 mutation, two cleaved fragments of
280- and 29-bp would be expected. The proportions of
mutant versus total mtDNA were calculated by densito-
metric analysis using QuantiScan software (Biosoft, UK).
Results and discussion
H&E-stained muscle biopsies showed marked variation in
ﬁber size, ranging from 15 to 115 lm in diameter. Some
ﬁbers had internal nuclei. Scattered, ragged red ﬁbers were
observed with modiﬁed Gomori trichrome stain, and a
succinate dehydrogenase (SDH) reaction revealed many
ragged red ﬁbers (RRF) (Fig. 3a). Several strongly SDH-
reactive blood vessels (SSVs) were highlighted (Fig. 3b).
Staining for cytochrome c oxidase (COX) activity dem-
onstrated the presence of scattered COX-deﬁcient ﬁbers,
and showed that SSVs were COX-negative (Fig. 3c). The
muscle biopsy also showed RRF/COX-positive ﬁber, as
evident from Fig. 3. The proportions of RRF and of COX
defective muscle ﬁbers found in our patient were 4.2 and
5.6%, respectively. The above ﬁndings are suggestive of
mitochondrial disease.
PCR–RFLP analysis using a modiﬁed set of primers that
speciﬁcally detects the 3291T ? C mutation in mtDNA
showed maternal inheritance of the mutation in a hetero-
plasmic manner (Fig. 1b). These ﬁndings demonstrate that
the 3291 mutation is pathogenic in this family.
Fig. 3 Light microscopy of muscle biopsy from patient II-4.
a Modiﬁed Gomori trichrome staining shows several ragged red
ﬁbers. b Succinate dehydrogenase reaction (SDH) shows numerous
hyperintense ﬁbers. Strongly SDH-reactive blood vessel (SSV) is
highlighted. c Cytochrome c oxidase (COX) reaction shows several
negative ﬁbers. Asterisk indicates that SSV is COX-negative. Scale
bars represent 50 lm (color ﬁgure online)
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123Previously, we identiﬁed a novel point mutation of the
tRNA-Leu(UUR) gene in a single patient affected by the
typical MELAS phenotype [1]. The second case involving
the 3291 mutation was reported by Uziel in an Italian child
with isolated, mild myopathy [2]. The third case with the
same mutation was revealed by Salsano in an Italian female
who presented with cognitive and behavioral disturbances,
and hearing loss [3]. Here we describe the third case with
an apparent family history. The symptoms of the proband
include severe cerebellar ataxia, myopathy, mild oph-
thalmoparesis, hearing loss, and asymptomatic EEG
abnormality. COX-negative SSV in biopsied muscle of the
patient (Fig. 3) is compatible with the histological ﬁndings
of myoclonic epilepsy and ragged red ﬁber (MERRF)
rather than MELAS [4]. Furthermore, clinical manifesta-
tions in the patient’s second daughter and the patient’s ﬁrst
grandchild are consistent with the MERRF phenotype. In
contrast, the patient’s ﬁrst daughter had recurrent migraine-
like attacks. These ﬁndings indicate that the same 3291
mutation in mtDNA can be associated with a wide spec-
trum of phenotypes, including MELAS and MERRF.
Interestingly, the symptoms within the family become
apparent at successively earlier ages as the condition is
passed to subsequent generations. Thus, not only the dis-
ease manifestations, but the age of onset is also variable.
MtDNA is transmitted only from females to their off-
spring, but a single female can bear offspring who harbor
different levels of mutant mtDNA. During oogenesis, the
mutant and normal mtDNA segregating units are dispersed
through repeated cell divisions, resulting in the proto-
oocytes segregating their mtDNA genotypes toward pre-
dominantly normal or mutant mtDNAs [5]. Some of the
phenotypic variability, especially that seen between
patients with the same mtDNA mutation, is undoubtedly
attributable to differences in the level of heteroplasmy
within an individual [6]. Moreover, the distribution of the
mutant mtDNA in different tissues varies widely among
individuals [7].
Analysis of mtDNA from peripheral leukocytes of our
patients estimated the proportions of mutant versus total
mtDNA as followed: II-4 11%, III-3 16% and IV-1 27%.
The amount of detection of the point mutation in blood
samples was age dependent (Fig. 1b). A similar tendency
was also evident for two previously reported patients with
neuromuscular disorders associated with the 3291 muta-
tion. Analysis using blood samples is not as sensitive,
particularly in older subjects. The absence of the mutation
in the blood samples suggests that there is a preferential
selection process for normal (wild type) mtDNA over time.
This may be related to the rate of cell division and energy
requirements of each tissue. By contrast, muscle is com-
posed of highly differentiated, post-mitotic syncythial
cells, in which no selection against cells containing
defective mitochondria can occur. The proband patient was
demonstrated to have the same mutation at high abundance
(74%) in the biopsied muscle (Fig. 1b).
Mitochondrial DNA is highly susceptible to mutation
and polymorphisms are common in the general population
[8]. The question arises, therefore, whether a mutation
detected in the mitochondrial genome of a patient with a
suspected mitochondrial disorder is a rare polymorphism or
a pathogenic mutation. Only recurrent mutations occurring
in different populations and segregating with the disease
phenotype in multigenerational pedigrees may be
undoubtedly classiﬁed as pathogenic mutations. Our ﬁnd-
ings provide conclusive characterization of the 3291 T[C
as a rare pathogenic mutation of mtDNA.
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